The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Down Syndrome Genetic Testing Market Research Report 2025

Global Down Syndrome Genetic Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1910447

No of Pages : 89

Ask Your Query
Synopsis
A method to detect Down syndrome
The global Down Syndrome Genetic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Down Syndrome Genetic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Down Syndrome Genetic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Down Syndrome Genetic Testing in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Down Syndrome Genetic Testing include Premed, Inmedi, Yin Feng Gene, KingMed, Topgen, Annoroad, Berrygenomics, Sanvalley and Abbott, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Down Syndrome Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Down Syndrome Genetic Testing.
Report Scope
The Down Syndrome Genetic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Down Syndrome Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Down Syndrome Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Premed
Inmedi
Yin Feng Gene
KingMed
Topgen
Annoroad
Berrygenomics
Sanvalley
Abbott
Illumina
Roche
Segment by Type
Genetic Screening
Reproductive Genetic Testing
Diagnostic Test
Gene carrier Test
Testing Before Symptoms Appear
Segment by Application
Hospital
Clinic
Diagnostic Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Down Syndrome Genetic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Down Syndrome Genetic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Genetic Screening
1.2.3 Reproductive Genetic Testing
1.2.4 Diagnostic Test
1.2.5 Gene carrier Test
1.2.6 Testing Before Symptoms Appear
1.3 Market by Application
1.3.1 Global Down Syndrome Genetic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Diagnostic Center
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Down Syndrome Genetic Testing Market Perspective (2019-2030)
2.2 Down Syndrome Genetic Testing Growth Trends by Region
2.2.1 Global Down Syndrome Genetic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Down Syndrome Genetic Testing Historic Market Size by Region (2019-2024)
2.2.3 Down Syndrome Genetic Testing Forecasted Market Size by Region (2025-2030)
2.3 Down Syndrome Genetic Testing Market Dynamics
2.3.1 Down Syndrome Genetic Testing Industry Trends
2.3.2 Down Syndrome Genetic Testing Market Drivers
2.3.3 Down Syndrome Genetic Testing Market Challenges
2.3.4 Down Syndrome Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Down Syndrome Genetic Testing Players by Revenue
3.1.1 Global Top Down Syndrome Genetic Testing Players by Revenue (2019-2024)
3.1.2 Global Down Syndrome Genetic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Down Syndrome Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Down Syndrome Genetic Testing Revenue
3.4 Global Down Syndrome Genetic Testing Market Concentration Ratio
3.4.1 Global Down Syndrome Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Down Syndrome Genetic Testing Revenue in 2023
3.5 Down Syndrome Genetic Testing Key Players Head office and Area Served
3.6 Key Players Down Syndrome Genetic Testing Product Solution and Service
3.7 Date of Enter into Down Syndrome Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Down Syndrome Genetic Testing Breakdown Data by Type
4.1 Global Down Syndrome Genetic Testing Historic Market Size by Type (2019-2024)
4.2 Global Down Syndrome Genetic Testing Forecasted Market Size by Type (2025-2030)
5 Down Syndrome Genetic Testing Breakdown Data by Application
5.1 Global Down Syndrome Genetic Testing Historic Market Size by Application (2019-2024)
5.2 Global Down Syndrome Genetic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Down Syndrome Genetic Testing Market Size (2019-2030)
6.2 North America Down Syndrome Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Down Syndrome Genetic Testing Market Size by Country (2019-2024)
6.4 North America Down Syndrome Genetic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Down Syndrome Genetic Testing Market Size (2019-2030)
7.2 Europe Down Syndrome Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Down Syndrome Genetic Testing Market Size by Country (2019-2024)
7.4 Europe Down Syndrome Genetic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Down Syndrome Genetic Testing Market Size (2019-2030)
8.2 Asia-Pacific Down Syndrome Genetic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Down Syndrome Genetic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Down Syndrome Genetic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Down Syndrome Genetic Testing Market Size (2019-2030)
9.2 Latin America Down Syndrome Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Down Syndrome Genetic Testing Market Size by Country (2019-2024)
9.4 Latin America Down Syndrome Genetic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Down Syndrome Genetic Testing Market Size (2019-2030)
10.2 Middle East & Africa Down Syndrome Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Down Syndrome Genetic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Down Syndrome Genetic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Premed
11.1.1 Premed Company Detail
11.1.2 Premed Business Overview
11.1.3 Premed Down Syndrome Genetic Testing Introduction
11.1.4 Premed Revenue in Down Syndrome Genetic Testing Business (2019-2024)
11.1.5 Premed Recent Development
11.2 Inmedi
11.2.1 Inmedi Company Detail
11.2.2 Inmedi Business Overview
11.2.3 Inmedi Down Syndrome Genetic Testing Introduction
11.2.4 Inmedi Revenue in Down Syndrome Genetic Testing Business (2019-2024)
11.2.5 Inmedi Recent Development
11.3 Yin Feng Gene
11.3.1 Yin Feng Gene Company Detail
11.3.2 Yin Feng Gene Business Overview
11.3.3 Yin Feng Gene Down Syndrome Genetic Testing Introduction
11.3.4 Yin Feng Gene Revenue in Down Syndrome Genetic Testing Business (2019-2024)
11.3.5 Yin Feng Gene Recent Development
11.4 KingMed
11.4.1 KingMed Company Detail
11.4.2 KingMed Business Overview
11.4.3 KingMed Down Syndrome Genetic Testing Introduction
11.4.4 KingMed Revenue in Down Syndrome Genetic Testing Business (2019-2024)
11.4.5 KingMed Recent Development
11.5 Topgen
11.5.1 Topgen Company Detail
11.5.2 Topgen Business Overview
11.5.3 Topgen Down Syndrome Genetic Testing Introduction
11.5.4 Topgen Revenue in Down Syndrome Genetic Testing Business (2019-2024)
11.5.5 Topgen Recent Development
11.6 Annoroad
11.6.1 Annoroad Company Detail
11.6.2 Annoroad Business Overview
11.6.3 Annoroad Down Syndrome Genetic Testing Introduction
11.6.4 Annoroad Revenue in Down Syndrome Genetic Testing Business (2019-2024)
11.6.5 Annoroad Recent Development
11.7 Berrygenomics
11.7.1 Berrygenomics Company Detail
11.7.2 Berrygenomics Business Overview
11.7.3 Berrygenomics Down Syndrome Genetic Testing Introduction
11.7.4 Berrygenomics Revenue in Down Syndrome Genetic Testing Business (2019-2024)
11.7.5 Berrygenomics Recent Development
11.8 Sanvalley
11.8.1 Sanvalley Company Detail
11.8.2 Sanvalley Business Overview
11.8.3 Sanvalley Down Syndrome Genetic Testing Introduction
11.8.4 Sanvalley Revenue in Down Syndrome Genetic Testing Business (2019-2024)
11.8.5 Sanvalley Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Down Syndrome Genetic Testing Introduction
11.9.4 Abbott Revenue in Down Syndrome Genetic Testing Business (2019-2024)
11.9.5 Abbott Recent Development
11.10 Illumina
11.10.1 Illumina Company Detail
11.10.2 Illumina Business Overview
11.10.3 Illumina Down Syndrome Genetic Testing Introduction
11.10.4 Illumina Revenue in Down Syndrome Genetic Testing Business (2019-2024)
11.10.5 Illumina Recent Development
11.11 Roche
11.11.1 Roche Company Detail
11.11.2 Roche Business Overview
11.11.3 Roche Down Syndrome Genetic Testing Introduction
11.11.4 Roche Revenue in Down Syndrome Genetic Testing Business (2019-2024)
11.11.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock